Literature DB >> 21386071

FDA takes slow road toward withdrawal of drug approved with fast-track process.

Mike Mitka.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21386071     DOI： 10.1001/jama.2011.269

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

Review 2.  Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials.

Authors:  Ajay K Parsaik; Balwinder Singh; Osama Altayar; Soniya S Mascarenhas; Shannon K Singh; Patricia J Erwin; M Hassan Murad
Journal:  J Gen Intern Med       Date:  2013-06-18       Impact factor: 5.128

3.  Erythropoiesis-stimulating agent use after changes in medicare reimbursement policies.

Authors:  Dawn L Hershman; Alfred I Neugut; Jin Joo Shim; Sherry Glied; Wei-Yann Tsai; Jason D Wright
Journal:  J Oncol Pract       Date:  2014-04-15       Impact factor: 3.840

Review 4.  New developments in the management of neurogenic orthostatic hypotension.

Authors:  Italo Biaggioni
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.